{"schema_version":"secwatch.filing_event.v1","accession":"0001672688-26-000047","form_type":"8-K","ticker":"ABSI","cik":"0001672688","company_name":"Absci Corp","filed_at":"2026-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.844575+00:00","generated_at":"2026-05-15T18:46:50.830932+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Absci appoints Ransi Somaratne as CMO; Chief Innovation Officer Andreas Busch to retire","bullets":["Ransi Somaratne, formerly SVP Clinical Development at Vertex, appointed CMO effective March 3, 2026.","Andreas Busch, Chief Innovation Officer, will retire March 31, 2026 and serve as scientific advisor for 2 years.","Busch receives $25,500 annual retainer plus grants of 22,800 stock options and 5,800 RSUs under the 2021 Plan.","Busch's vested options (2,489,290 shares) extended up to 3 months post-advisory termination; unvested options cancelled.","Amended director and officer indemnification agreements adopted March 6, 2026, enhancing change-in-control and good faith provisions."],"urls":{"canonical":"https://secwatch.observer/filing/0001672688-26-000047","json":"https://secwatch.observer/filing/0001672688-26-000047.json","markdown":"https://secwatch.observer/filing/0001672688-26-000047.md","text":"https://secwatch.observer/filing/0001672688-26-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1672688/000167268826000047/0001672688-26-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1672688/000167268826000047/absc-20260303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T18:46:50.830932+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}